SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,132.81 -382.62
( -0.50%)

Global Indices

Nasdaq

53,435.25 -271.85
(-0.51%)

Dow Jones

7,739.60 -29.11
(-0.37%)

Hang Seng

66,225.50 1,204.56
(1.85%)

Nikkei 225

10,817.95 -13.14
(-0.12%)

Forex

USD-INR

94.48 -0.24
(-0.26%)

EUR-INR

109.71 0.00
(0.00%)

GBP-INR

127.63 -0.19
(-0.15%)

JPY-INR

0.60 0.01
(1.60%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajooni Biotech Ltd

Industry : Food - Processing - Indian

BSE Code

ISIN Demat

Book Value()

535040

INE820Y01021

5.2941717

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJOONI

15.17

60.11

EPS(TTM)

Face Value()

Div & Yield %

0.23

Back

Dr Lal Pathlabs consolidated net profit rises 28.02% in the June 2026 quarter

Jul 24,2026

Net profit of Dr Lal Pathlabs rose 28.02% to Rs 169.50 crore in the quarter ended June 2026 as against Rs 132.40 crore during the previous quarter ended June 2025. Sales rose 19.10% to Rs 797.70 crore in the quarter ended June 2026 as against Rs 669.80 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	797.70	669.80	19
OPM %	31.03	28.71	-
PBDT	273.10	215.70	27
PBT	228.70	181.10	26
NP	169.50	132.40	28

76,132.81 -382.62 ( -0.50%)

53,435.25 -271.85 (-0.51%)

7,739.60 -29.11 (-0.37%)

66,225.50 1,204.56 (1.85%)

10,817.95 -13.14 (-0.12%)

94.48 -0.24 (-0.26%)

109.71 0.00 (0.00%)

127.63 -0.19 (-0.15%)

0.60 0.01 (1.60%)